Immutep Statistics

Total Valuation

Immutep has a market cap or net worth of $66.59 million. The enterprise value is -$3.64 million.

Market Cap	66.59M
Enterprise Value	-3.64M

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Immutep has 1.47 billion shares outstanding. The number of shares has increased by 9.74% in one year.

Current Share Class	n/a
Shares Outstanding	1.47B
Shares Change (YoY)	+9.74%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	2.66%
Owned by Institutions (%)	52.23%
Float	1.23B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.60
Forward PS	3.34
PB Ratio	1.01
P/TBV Ratio	1.07
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.01.

Current Ratio	2.97
Quick Ratio	2.91
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,164.41

Financial Efficiency

Return on equity (ROE) is -61.85% and return on invested capital (ROIC) is -38.57%.

Return on Equity (ROE)	-61.85%
Return on Assets (ROA)	-32.10%
Return on Invested Capital (ROIC)	-38.57%
Return on Capital Employed (ROCE)	-84.46%
Weighted Average Cost of Capital (WACC)	16.83%
Revenue Per Employee	$170,472
Profits Per Employee	-$1.81M
Employee Count	31
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.10% in the last 52 weeks. The beta is 2.32, so Immutep's price volatility has been higher than the market average.

Beta (5Y)	2.32
52-Week Price Change	-70.10%
50-Day Moving Average	1.27
200-Day Moving Average	1.88
Relative Strength Index (RSI)	33.52
Average Volume (20 Days)	40,324,280

Short Selling Information

The latest short interest is 1.25 million, so 0.87% of the outstanding shares have been sold short.

Short Interest	1.25M
Short Previous Month	1.31M
Short % of Shares Out	0.87%
Short % of Float	n/a
Short Ratio (days to cover)	0.04

Income Statement

In the last 12 months, Immutep had revenue of $5.28 million and -$55.97 million in losses. Loss per share was -$0.04.

Revenue	5.28M
Gross Profit	-49.88M
Operating Income	-56.44M
Pretax Income	-55.97M
Net Income	-55.97M
EBITDA	-54.96M
EBIT	-56.44M
Loss Per Share	-$0.04

Full Income Statement

Balance Sheet

The company has $66.12 million in cash and $806,834 in debt, giving a net cash position of $65.31 million or $0.04 per share.

Cash & Cash Equivalents	66.12M
Total Debt	806,834
Net Cash	65.31M
Net Cash Per Share	$0.04
Equity (Book Value)	65.97M
Book Value Per Share	0.04
Working Capital	61.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.46 million and capital expenditures -$84,662, giving a free cash flow of -$44.72 million.

Operating Cash Flow	-41.46M
Capital Expenditures	-84,662
Depreciation & Amortization	1.60M
Net Borrowing	-190,271
Free Cash Flow	-44.72M
FCF Per Share	-$0.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,068.07%
Pretax Margin	-1,059.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immutep does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.74%
Shareholder Yield	-9.74%
Earnings Yield	-84.05%
FCF Yield	-67.15%

Analyst Forecast

The average price target for Immutep is $5.50, which is 1,028.44% higher than the current price. The consensus rating is "Hold".

Price Target	$5.50
Price Target Difference	1,028.44%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	116.35%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 28, 2016. It was a reverse split with a ratio of 1:3.33.

Last Split Date	Dec 28, 2016
Split Type	Reverse
Split Ratio	1:3.33

Scores

Immutep has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.55
Piotroski F-Score	2